Cargando…
Is ivermectin ready to be part of a public health policy for COVID-19 prophylaxis?
Autores principales: | Ramírez, Céleo, Herrera-Paz, Edwin F., Peralta, Guímel, Rodríguez, Gaspar, Durón, Reyna M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7859718/ https://www.ncbi.nlm.nih.gov/pubmed/33558858 http://dx.doi.org/10.1016/j.eclinm.2021.100744 |
Ejemplares similares
-
The Russia-Ukraine war could bring catastrophic public-health challenges beyond COVID-19
por: Ramírez, Céleo, et al.
Publicado: (2022) -
Dealing with perceptions related to thrombosis and COVID-19 vaccines
por: Ramírez, Céleo, et al.
Publicado: (2021) -
COVID-19 vaccination policies and the new challenges of international travel
por: Ramírez, Céleo, et al.
Publicado: (2022) -
Challenges managing COVID vaccine-induced immune thrombotic thrombocytopenia in low-middle income countries
por: Ramírez, Céleo, et al.
Publicado: (2021) -
Differences in inflammatory markers between coronavirus disease 2019 and sepsis in hospitalised patients
por: Linarez Ochoa, Nery E., et al.
Publicado: (2022)